ABSTRACT. The least abundant stable isotope of iron, "Fe (natural abundance 0.322 weight %), was administered orally to infants to explore the feasibility of using a stable rather than a radioisotope in studies of iron absorption. The dose of 58Fe was given between feedings at age 126 days. The mass isotope ratio, 58Fe/57Fe, was determined in blood by inductively coupled plasma mass spectroscopy and at ages 
Iron deficiency is a leading nutritional deficiency disorder among infants and children both in industrialized and developing countries (1) . Although it is well recognized that development of strategies for prevention of iron deficiency requires sound knowledge of iron absorption, studies to provide this knowledge have been impeded by reluctance to administer radioisotopes to young subjects. We have recently demonstrated the feasibility of using the least abundant stable isotope of iron, "Fe (natural abundance 0.322 weight %), for studies of iron metabolism in infants and have reported data from study of four infants (2) . We reported the MIR 58/57 in erythrocytes for each of four infants at 84 and 112 days of age (baseline values) and at 140, 168, and 196 days of age. A dose of "Fe was administered to each infant under standardized conditions at 126 days of age. We concluded that 58Fe was promising as a tracer for studies of iron availability in infants.
We have now studied an additional five infants and, from the pooled data, have made estimates of the apparent errors of the method. We have also demonstrated for the first time in infants a negative correlation between serum fenitin concentration and erythrocyte incorporation of iron.
METHODS
Subjects. The subjects were normal Caucasian term infants recruited from those enrolled in studies of food intake and growth in the Division of Nutrition, Department of Pediatrics, University of Iowa. The protocol was approved by the University of Iowa Committee on Research Involving Human Subjects. The parents of the infants were fully informed and consent forms were signed. The infants were managed as previously described (3, 4) except that formula was the sole source of energy intake until 140 days of age. As in other reports, we have used particular age designations (e.g. 112 days) although each of these ages in practice may be +4 days.
Feedings. From birth to 112 days of age and from 128 to 196 days of age the infants were fed ready-to-feed (i.e. 67 kcal/dl) milk-based formulas or formulas based on isolated soy protein.
The various study designs resulted in the provision of 12 mg of iron in the form of ferrous sulfate per liter of formula during all or most of the first 112 days of life and during the interval 128 to 196 days of age. Because we believed that absorption of the test dose of iron would be enhanced if the prior intake of iron was low ( 3 , the infants were fed from 112 to 128 days of age a ready-to-feed milk-based formula (Enfamil, Mead Johnson and Company, Evansville, IN) providing 1.5 mg of iron in the form of ferrous sulfate per liter of formula. Commercially prepared strained foods were introduced into the diet at 140 days of age.
Blood samples. Infants visited the Division of Nutrition at specified ages from soon after birth until completion of study. These visits included ages 84, 112, 140, 168, and 196 days. With few exceptions, a sample of 6 ml venous blood was obtained at each of these visits.
Administration of "Fe label. A preparation of 58Fe-enriched elemental iron powder under inert atmosphere was purchased from Oak Ridge National Laboratory (Oak Ridge, TN). The isotopic composition of this preparation was (weight %) 54Fe 1.07, 56Fe 23.1, 57Fe 1.84, 58Fe 74.0. The natural isotopic composition of iron (weight %) is 54Fe 5.6 1, 56Fe 9 1.9, 57Fe 2.18, "Fe 0.322.
The elemental iron powder was dissolved in 1 N sulfuric acid as previously described (2) and stored under nitrogen in sealed ampoules, each containing 1.95 mg of total iron as ferrous sulfate, including 1.44 mg of '*Fe, in 5 ml. The solution pH was 1.8 k 0.1. For administration to the infant, 84 mg of sodium ascorbate, 400 mg of sucrose, and 1 drop of cherry flavor were added directly to the ampoule. The large dose of sodium ascorbate was added to enhance iron absorption (6) and the sucrose and cherry flavor to increase palatability. The contents were mixed gently by drawing a portion of the solution into a syringe with an 18- ( I F INGESTED 58-IRON BY INFANTS   2 1 gauge needle and returning it to the ampoule. This procedure was repeated several times and the entire volume was then delivered from the syringe into the infant's mouth. Neither vial nor syringe was rinsed.
ERYTHROCYTE INCORPORATION
At age 126 days each infant visited the Division of Nutrition and was given the dose of 1.95 mg of iron (containing 1.44 mg of 58Fe) orally midmorning, approximately 2 h after and 2 h before a formula feeding. Two of the previously reported infants (subjects 3 165 and 3342) were given a second dose of 58Fe in the same amount and in the same manner on the next day. The first blood sample after administration of "Fe was obtained 14 The 58Fe/57Fe isotope ratio was measured by ICP/MS as described previously (2) . The ratio of the least abundant (58Fe) to the next least abundant (57Fe) isotope of iron provides for the greatest precision of measurement. Samples (1.0 ml or,less) of heparinized whole blood were wet ashed with concentrated HN03 and small amounts of H202. The digest solutions were diluted with water and the pH adjusted to 2.0 + 0.1 by addition of NH40H. Iron was precipitated with the chelating agent, ammonium pyrrolidinedithiocarbamate and the precipitate redissolved in the least possible volume of concentrated HN03. Solution volume was adjusted with deionized water to yield iron concentration of about 10 pg/ml.
The 58Fe/57Fe ratio was expressed on a weightlweight basis (pg 58Fe/pg 57Fe) and denoted as MIR58/57. Isotope standards for daily instrument calibration were prepared from solutions of human blood digested in the same manner as unknown samples. They were spiked with increasing amounts of enriched 58Fe solution to provide isotope ratios covering the range of anticipated isotope ratios in unknown samples. The MIR58157 of the isotope standards were calculated from the iron content of the blood digests determined before spiking and the known amount of 58Fe and 57Fe in each spike.
Unknown samples and isotope standards were analyzed for the MIR58/57 using the Elan 250 ICP/MS System (SCIEX, Inc., Thornhill, Ontario, Canada) operated in the isotope ratio mode. Normally, the mean of ten sequential measurements of the ion beam intensities was recorded. No background corrections were made. This value was referred to as the MR58157. The coefficient of variation for the 10 measurements was usually less than 1 %. Isotope standards were run daily. To avoid the possibility of contamination, the standards were run after the unknown samples. The value of MR58/57 is not affected by changes in the ion intensity that might occur during the course of several hours of operation. For each day of operation the values of MR5sls7 for isotope standards were plotted against the respective calculated MIR58/57 values. MIR58/57 values of unknown samples were read from the resulting least-squares regression equation.
Calculation of quantity of administered 58Fe incorporated into erythrocytes. The quantity of administered 58Fe incorporated into erythrocytes (58Fei,c) at a specified time t after administration of the dose of 58Fe was calculated as follows:
where 58Fei,, is expressed in mg, MIRt58/57 is the determined MIR5g/57 at time t after dosing, M1R058/57 is the determined baseline ratio, FeCi, is the quantity of total circulating iron (mg) at time t, and 0.00322 is the natural abundance (weight fraction) of 58Fe.
The quantity of total circulating iron (mg) was estimated as follows:
where BV is blood volume in ml, assumed to be 65 ml/kg of body weight, Hb concentration is in g/ml, and 3.47 is the concentration of iron in Hb (mg/g). The assumed value for blood volume per unit of body weight is almost identical to the mean value of 66 ml/kg reported by Bratteby (7) for eight normal infants between 100 and 138 days of age.
58Fein, was expressed either absolutely (mg) or as a percentage of the administered dose of 58Fe and is henceforth referred to as "circulating 58Fe label."
Use of repeated MIR58/57 determinations for estimate of error. When a radioactive iron tracer, 59Fe or 55Fe, is administered orally to normal or iron-deficient adult subjects, 80% or more of the absorbed dose appears promptly (i.e. within 10 days) in the circulating erythrocytes (1) . Little is known about the extent to which newly absorbed iron is incorporated into erythrocytes of infants; however, with infants, as with hematologically normal and iron-deficient adults, it seems probable that newly absorbed iron has priority for incorporation into erythrocytes. Thus, enrichment with 58Fe will be found predominantly in erythrocytes formed in close temporal proximity to dosing with 58Fe. Erythrocytes that are eliminated from the circulation between 140 and 196 days of age will be almost exclusively older cells that are not enriched with 58Fe, and new erythrocytes appearing in the circulation between 140 and 196 days of age will have been formed primarily with iron absorbed during that interval. Small amounts of the 58Fe label absorbed at age 126 days and not incorporated into erythrocytes by 140 days of age might be incorporated into erythrocytes between 140 and 196 days of age, but for these infants who were receiving generous intakes of iron daily, such contribution to erythrocyte 58Fe will probably be trivial. Thus, the MIR58157 determined at 140 days of age (i.e. 14 days after administration of iron) will be slightly more than the MIRss/57 determined at age 168 days, and the value at age 168 days will be slightly more than that at age 196 days. However, the quantity of circulating 58Fe label should remain constant.
We therefore estimated the error of the method from the variation in the quantities of 58Fe label in the circulation at ages 140, 168, and 196 days.
RESULTS
Data on body weight, Hb concentration, hematocrit, serum fenitin concentration, reticulocyte count, and MIR58157 are presented in Table 1 for each infant at ages 84, 112, 140, 168, and 196 days.
There were no significant age-related changes in Hb concentration, hematocrit, or reticulocyte count. However, serum ferritin concentrations were greater at younger than at older ages. The decrease in femtin concentration was significant for the age interval 84 to 196 days (analysis of variance: linear trend, p < 0.04).
MIR58157 values and circulating 58Fe label. The MIR58/57 at the natural abundance level is 0.1475 (i.e. 0.00322 + 0.02183). Incompletely understood factors believed to relate to instrument operation result in variation in determined MIR05s/57 ( Table 1) . The mean MIR058157 of the first four infants studied was 0.1465 (SD 0.0019, eight determinations). MIR058157 values of the five additional infants (mean 0.1438, SD 0.0020, six determinations) were significantly ( p < 0.05) lower. One value (subject 3378, age 1 12 days) was excluded as an outlier (Table 1 ). In our calculations we have used the mean determined values as the baselines for the original four and the additional five infants, respectively. Values for circulating 58Fe label (58Fe,,c) are presented in Table  2 . The difference between values for 140, 168, and 196 days of age was not statistically significant (analysis of variance). For each subject the mean of all three values is presented both in absolute terms (mg) and as a percentage of the administered dose. The circulating 58Fe label accounted for 3.2 to 16.0% of the administered dose, with a geometric mean of 7.9 %. The data in Table 2 include results for four subjects identified in our earlier report (2) . The values for percentage of circulating 58Fe label presented in Table 2 differ somewhat from those presented previously because of erroneous values for Hb concentrations in the earlier report.
Relation between circulating 58Fe label and indices of iron nutritional status. Because we did not obtain a sample of blood on the day on which the dose of 58Fe was administered (age 126 days), we used the average value for 1 12 and 140 days of age as most representative for Hb concentration, hematocrit, reticulocyte count, and serum femtin concentration to explore the relation between percentage circulating label and each of the specified hematologic indices.
The percentage circulating 58Fe label was not significantly correlated with Hb concentration, hematocrit, or reticulocyte count but was correlated with serum concentration of fenitin (Spearman rank correlation, r = -0.867, p < 0.01; log-log correlation r = -0.836, p < 0.01). As may be seen from Figure   1 , at low levels of serum femtin (40 ng/ml or less), a relatively high percentage of the label was present in circulating erythrocytes (6 infants, range 7.4 to 16.0% of dose). However, at higher levels of serum femtin, a smaller percentage of the label appeared in the circulation (three infants, range 3.2 to 3.8% of dose). On the whole, serum fenitin concentration explained 70 to 75% of the variation in circulating 58Fe label ( 9 values).
Estimation of error.
As an initial approach to estimating the error of the method, we determined the uncertainty of the value of "Feint (equation 1) resulting solely from the uncertainties in the measurement of MIR058/57 and MIRt58/57. For consideration, we chose a 7000 g infant with Hb concentration of 0.1 1 g/ml and MIR058l5, of 0.1456 (SD 0.001 5). With the assumption that the coefficient of variation of M1R58/57 determinations was 1% as previously reported (2), we calculated the uncertainty of 58Feinc by propagation of errors through equation 1 with 1) M1Rt58/57 of 0.1602 and 2) MIRts8/57 of 0.2 184. In example I), the calculated value for 58Fein, is 3.9% of intake (SD 0.6%; CV 15%). In example 2), the calculated value for "Fei,, is 19.4% (SD 0.7%; CV 3.6%).
A separate approach to estimating the error was provided by the variation with each subject between values for circulating "Fe label at ages 140, 168, and 196 days ( Table 2) . Although the SD of percentage circulating label were relatively low, ranging from 0.22 to 1.28% (arithmetic mean 0.62%) of the dose, the CV ranged from 1.0 to 30.5% (arithmetic mean 9.7%), the highest value pertaining, not unexpectedly, to one of the subjects with relatively low percentage circulating "Fe label. For the six subjects with fenitin concentration of less than 40 ng/ml the mean coeficient of variation was 5.6%.
The similarity of the SD and the CV obtained by the propagation of errors approach (which reflects only the error in MIR58/ 57 determinations) and those calculated from the determined values for 58Fei,, at ages 140, 168, and 196 days suggests that the major source of error is in the MIR58/57 determinations.
DISCUSSION
With the exception of our preliminary report concerning determination of 58Fe enrichment of erythrocytes by ICP/MS (2), studies of iron availability with stable isotopes have been based on determinations of fecal excretion of the isotope (8, 9) . Data presented herein suggest the feasibility of studies in which "Fe enrichment of erythrocytes rather than fecal excretion of "Fe serves as the endpoint. Several questions, such as the relative absorption of fortification iron from foods, can be answered less expensively and probably more convincingly by determining 58Fe enrichment of erythrocytes than by "Fe metabolic balance studies.
There is only one previous report of erythrocyte incorporation of an iron isotope by infants after an oral dose of iron administered between feedings. Rios et al. (10) fed 1.44 mg of ferrous ascorbate tagged with 59Fe under conditions quite similar to those of our study. In three feeding groups of 13 to 15 infants each, geometric mean retentions were reported to be 6.4, 7.8, and 5.8% of intake. If we assume, as was done by Rios et al. (lo) , that 90% of absorbed iron was present in erythrocytes 14 days after administration of the test dose, geometric mean retention in our study was 8.8% of intake (7.9% + 0.9).
Little information is available concerning the percentage of absorbed iron promptly incorporated into the circulating erythrocytes of infants. Garby et al. (1 1) administered small amounts of 59Fe intravenously to infants and determined the percentage of the administered dose present in circulating erythrocytes at various intervals thereafter. Judging from the graphic data presented by these authors, 9 to 14 days after administration approximately 65% of the dose was present in erythrocytes of one infant injected at age 65 days, and approximately 85% of the dose was present in erythrocytes of three infants injected at ages 8 1 to 129 days. Data are not available concerning older infants and we find no reason to reject the assumption of Rios et al. (10) that 90% of retained iron appeared promptly in erythrocytes of the 4-to 6-month-old infants in their study. To obtain additional information on this point, we are conducting "Fe metabolic balance studies concurrently with studies of 58Fe incorporation into erythrocytes.
Although the report by Rios et al. (10) is the only report of erythrocyte incorporation of radioiron given to infants between feedings, retention of oral doses of radioiron given to infants between feedings has been determined by metbolic balance studies (1 2, 1 3) or by whole body counting (1 4-16) . In all but two of these studies (14, 15) , the dose of iron was much higher [30 to 60 mg in the study of Schulz and Smith (12) ] or lower [20 pg or less in the studies by Garby and Sjolin (13) , and by Saarinen et al. (16) l. Therefore, the most relevant data appear to be those of Heinrich et al. (14, 15) .
Heinrich et al. (14, 15) If we assume that 90% of the retained iron is present in the circulating erythrocytes 14 days after administering the test dose, the extent of retention in our study with the dose of 1.95 mg of iron was substantially less than that reported by Heinrich et al. (14, 15) . In our study, the greatest retention was probably no more than 17.7% of the dose (Table 2, subject 3342: 16.0% -+ 0.9 = 17.7%), a value slightly less than the mean values reported by Heinrich et al. (14, 15) with doses of 0.56 mg (20.7% retention) or 5 mg (1 8.0% retention).
The most likely explanation for the difference in retention reported by Heinrich et al. (14, 15) and by us is the timing of 58Fe administration in relation to feeding. The infants studied by Heinrich et al. (14, 15) were given the dose of iron 5 h after a feeding, whereas the infants in our study were given the dose 2
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h after a feeding. Thus, in our study there was greater likelihood of inhibition of iron absorption by mixing of the dose with formula or formula components in the stomach or upper small intestine. Studies of adult subjects given oral doses of radioisotopes of iron under standardized, fasting conditions have demonstrated a significant inverse relationship between percentage of the dose of 59Fe absorbed and serum femtin concentration (17) (18) (19) (20) (21) (22) . As would be expected, the correlation is higher when the population studied includes both normal and iron-deficient subjects. Even when the analysis is restricted to iron-suficient subjects, the correlation is significant. In iron-sufficient adult subjects, Walters et al. (18) reported a correlation coefficient of -0.398 ( p < 0.005) for the regression of percent absorption on serum ferritin concentration and Heinrich et al. (20) reported a correlation coefficient of -0.356 ( p < 0.01) for the regression of log serum femtin concentration on percent absorption. Neither Walters et al. (1 8) nor Heinrich et al. (20) calculated the regression on a sex-specific basis, although there was a significant sex-related difference in serum concentration of femtin among the subjects studied by Walters et al. (18) and probably among the subjects studied by Heinrich et al. (20) .
Because the infants in our study were a relatively homogeneous group with respect to birth weight and known intake of iron from the time of birth, and because our conditions of administration of the iron dose were less well controlled (i.e. the dose could not be given in the postabsorptive state), we were surprised to observe the relatively high correlation between percent of circulating 58Fe label and serum femtin concentration.
The availability of normal, term infants for longitudinal study made it possible for us to adhere to a rather rigid protocol. The dose of 58Fe was administered to all infants under standardized conditions at the same age (126 + 4 days) and follow-up samples of blood were obtained at 140. 168. and 196 davs of age. Calculations based on these three'follok-up values permitted i n estimate of error of the value obtained in the determination of erythrocyte incorporation of 58Fe. This error, which includes the errors in the determinations of M1R58,57 and Hb concentration and the effect of certain assumptions, was rather modest (generally less than 1 % of the dose) ( Table 2 ). Such errors are probably acceptable for within-subject comparisons of iron availability from foods. In view of the large between-subject variation (3.2 to 16.0% of the dose incorporated into erythrocytes), we are pessimistic about the usefulness of study designs based on group comparisons of infants in this age group. However, group comparisons of older infants with less diversity in iron nutritional status (as reflected by serum femtin concentration) may be feasible.
The analytical method of ICP/MS used herein is potentially capable of an order of magnitude better precision (0.1%) than achieved at present on a routine basis (2) . If such an analytical precision could be achieved routinely, a number of important advances would be possible. The most significant of these concern the simultaneous use of two stable isotopes of ir~n-~*Fe and 57Fe. The ability to make precise measurements of two stable isotopes of iron would greatly increase the value of the approach. Absorption of nonheme iron from a meal, determined with the use of one stable isotope as an extrinsic tag, could be related to absorption of iron (tagged with the second stable isotope) from an aqueous solution of iron administered under standard conditions. Alternatively, iron absorption from two foods or two meals could be compared, one food or meal fed on the first day and the other on the second day. Finally, one stable isotope could be used to tag nonheme iron and the other to tag heme iron in the same meal.
